Lithobid (lithium carbonate USP)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   May 2016 WARNINGS Lithium Toxicity (addition of paragraph) The risk of lithium toxicity is increased in patients...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts